Second-line treatment strategy following CDK4/6 inhibitors for HR-positive and HER2-negative metastatic breast cancer patients: a multicentric, retrospective, observational study

Breast Cancer Research and Treatment 2026

View at publisher
Authors: Olivia Lavigne, François Poumeaud, Thibaut Reverdy, Van Tuat Huynh, Guillaume Roces, Gaulthier Poupin, Maureen Gouillou, Angélique Bobrie, Emma Donadille, Florence Dalenc, William Jacot, Julien Robert
+1 more Frédéric Fiteni
DOI: 10.1007/s10549-025-07893-2
Cited by: 1
References: 20

Fields of Study & Subjects

Advanced Breast Cancer Therapies HER2/EGFR in Cancer Research Cancer Treatment and Pharmacology

Publication details

Journal / source
Breast Cancer Research and Treatment
Publisher
Springer Science and Business Media LLC
Volume
215
Issue
3
Pages
63–63
Publication date
27 January 2026
Language
EN